Market Cap 5.75M
Revenue (ttm) 27.38M
Net Income (ttm) -167.95M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -613.40%
Debt to Equity Ratio 0.00
Volume 118,703,398
Avg Vol 26,170,799
Day's Range N/A - N/A
Shares Out 154.59M
Stochastic %K 6%
Beta 1.91
Analysts Sell
Price Target $1.00

Company Profile

Aktis Oncology, Inc. operates as a clinical-stage oncology company that engages in the development of targeted radiopharmaceutical therapies for cancer treatment. The company offers a miniprotein radioconjugate platform to discover and develop radiopharmaceutical therapies that deliver the tumor-killing properties of radioisotopes. It offers Nectin-4, a miniprotein radioconjugate for the treatment of locally advanced or metastatic urothelial cancer. Its products include AKY-1189 to deliver a rad...

Industry: Biotechnology
Sector: Healthcare
Phone: 617-461-4023
Address:
17 Drydock Avenue, Suite 17-401, Boston, United States
PHARMD09
PHARMD09 Mar. 21 at 2:26 PM
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 19 at 8:46 PM
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 17 at 4:40 PM
RAD 101 Imaging Agent Achieves Concordance with MRI in Suspected Brain Mets | CancerNetwork $RADX $CATX $AKTS $LNTH https://www.cancernetwork.com/view/rad-101-imaging-agent-achieves-concordance-with-mri-in-suspected-brain-mets
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 15 at 3:07 PM
B7-H3 https://www.linkedin.com/pulse/b7-h3-antibody-market-segmentation-size-trends-2026-2033-4agzf?utm_source=share&utm_medium=member_ios&utm_campaign=share_via $RADX $AKTS
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 13 at 4:43 PM
Diamond in the Rough $RADX $PYXS $IMNM $SMMT $AKTS
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 13 at 1:20 PM
$LLY $NVS $RADX $LNTH $AKTS RADX only value play
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 13 at 3:20 AM
It’s possible RAD101 could be a $1 to $1.5 billion dollar brain imaging tracer. If it becomes the gold standard. Brain tumors in general live off fatty acids. Therefore that’s why it finds them and lights them up. But radiologist could potentially use it before stereotactic radiation because mri’s don’t always pick up very small brain Mets and definitely after stereotactic radiation because standard mri’s don’t work well after necrosis cause by the radiation laser (gamma or cyber knife). What’s interesting phase2a 10/10 and phase 2b 11/12. Also, there’s a major market for this in European and Asia as well. $RADX $LNTH $AKTS $CATX
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 11 at 10:36 PM
Radiopharm: "Hold" As Theranostics Pipeline Has Several 2026 Milestones (NASDAQ:RADX) | Seeking Alpha $RADX $AKTS $NVS $LNTH https://seekingalpha.com/article/4881314-radiopharm-hold-as-theranostics-pipeline-has-several-2026-milestones
2 · Reply
RadioIsotope25
RadioIsotope25 Mar. 10 at 2:45 PM
Radiopharm Theranostics (ASX: RAD) KOL Webinar with Dr Ramji Rajendran - YouTube $RADX $CATX $AKTS $LNTH https://www.youtube.com/watch?v=d1lhPMFcrvY
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 8 at 2:12 AM
Radiopharm Theranostics: Harnessing isotopes & targeting agents to treat tumours - YouTube $RADX $AKTS $CATX $DAWN https://www.youtube.com/watch?v=A0cOYUeqXGg
0 · Reply
PHARMD09
PHARMD09 Mar. 21 at 2:26 PM
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 19 at 8:46 PM
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 17 at 4:40 PM
RAD 101 Imaging Agent Achieves Concordance with MRI in Suspected Brain Mets | CancerNetwork $RADX $CATX $AKTS $LNTH https://www.cancernetwork.com/view/rad-101-imaging-agent-achieves-concordance-with-mri-in-suspected-brain-mets
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 15 at 3:07 PM
B7-H3 https://www.linkedin.com/pulse/b7-h3-antibody-market-segmentation-size-trends-2026-2033-4agzf?utm_source=share&utm_medium=member_ios&utm_campaign=share_via $RADX $AKTS
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 13 at 4:43 PM
Diamond in the Rough $RADX $PYXS $IMNM $SMMT $AKTS
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 13 at 1:20 PM
$LLY $NVS $RADX $LNTH $AKTS RADX only value play
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 13 at 3:20 AM
It’s possible RAD101 could be a $1 to $1.5 billion dollar brain imaging tracer. If it becomes the gold standard. Brain tumors in general live off fatty acids. Therefore that’s why it finds them and lights them up. But radiologist could potentially use it before stereotactic radiation because mri’s don’t always pick up very small brain Mets and definitely after stereotactic radiation because standard mri’s don’t work well after necrosis cause by the radiation laser (gamma or cyber knife). What’s interesting phase2a 10/10 and phase 2b 11/12. Also, there’s a major market for this in European and Asia as well. $RADX $LNTH $AKTS $CATX
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 11 at 10:36 PM
Radiopharm: "Hold" As Theranostics Pipeline Has Several 2026 Milestones (NASDAQ:RADX) | Seeking Alpha $RADX $AKTS $NVS $LNTH https://seekingalpha.com/article/4881314-radiopharm-hold-as-theranostics-pipeline-has-several-2026-milestones
2 · Reply
RadioIsotope25
RadioIsotope25 Mar. 10 at 2:45 PM
Radiopharm Theranostics (ASX: RAD) KOL Webinar with Dr Ramji Rajendran - YouTube $RADX $CATX $AKTS $LNTH https://www.youtube.com/watch?v=d1lhPMFcrvY
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 8 at 2:12 AM
Radiopharm Theranostics: Harnessing isotopes & targeting agents to treat tumours - YouTube $RADX $AKTS $CATX $DAWN https://www.youtube.com/watch?v=A0cOYUeqXGg
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 5 at 2:58 PM
$LNTH $CATX $RADX $AKTS It’s either radiopharma stocks or it’s wrong.
0 · Reply
SuperGreenToday
SuperGreenToday Mar. 4 at 2:05 PM
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 4 at 12:25 AM
Lantheus is on Fire…$LNTH give some of that hot sauce to Radiopharm Theranostics in which Lantheus owns 15%. And we’re on the 3 yard line for confirmatory Phase2b rad101 data. stock went to $24 last on interim phase 2b data in Dec @ 92% meeting its goal. $RADX $AKTS $CATX
0 · Reply
Gator5326
Gator5326 Mar. 3 at 6:44 PM
$AKTS Great presentation. I love being early in a stock.
0 · Reply
Gator5326
Gator5326 Mar. 1 at 6:52 PM
$AKTS Some a holes think this is a RADX thread. 🤦‍♂️
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 28 at 4:39 PM
$RADX Terbium and Lutetium $AKTS $CATX $IMNM https://youtu.be/AOalQM8zfDM
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 26 at 1:08 AM
Ceo of $RADX ran global breast cancer business at $NVS and was chief commercial officer for their radoopharmaceuticals business AAA.. $CATX $AKTS
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 25 at 5:39 PM
HER2 can be the next major driver in Radiopharmaceutical’s ahead of PSMA and RAD202 is positioned to take advantage of it. $RADX $AKTS $CATX
1 · Reply
RadioIsotope25
RadioIsotope25 Feb. 25 at 3:32 AM
Radiopharm Theranostics M&A valuation metrics $AKTS $CATX $RADX
0 · Reply
focafoca99
focafoca99 Feb. 24 at 2:45 PM
$AKTS fast track designation, nice news this morning!
0 · Reply
focafoca99
focafoca99 Feb. 24 at 2:24 PM
$AKTS fast track designation, nice news this morning!
0 · Reply
TheTradeXchange
TheTradeXchange Feb. 24 at 1:01 PM
$AKTS - Aktis Oncology Receives U.S. FDA Fast Track Designation for AKY-1189, a Nectin-4 Miniprotein Radioconjugate
0 · Reply